Oasmia Pharmaceutical Ab (OASM) Stock Price & Overview
NASDAQ:OASM
Current stock price
The current stock price of OASM is 1.55 null. Today OASM is up by 1.97%. In the past month the price decreased by -15.35%. In the past year, price decreased by -13.89%.
OASM Key Statistics
- Market Cap
- 116.199M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.29
- Dividend Yield
- N/A
OASM Stock Performance
OASM Stock Chart
OASM Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to OASM. When comparing the yearly performance of all stocks, OASM is a bad performer in the overall market: 65.76% of all stocks are doing better.
OASM Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to OASM. OASM may be in some trouble as it scores bad on both profitability and health.
OASM Earnings
OASM Forecast & Estimates
OASM Financial Highlights
Over the last trailing twelve months OASM reported a non-GAAP Earnings per Share(EPS) of -0.29. The EPS decreased by -11.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -8636.74% | ||
| ROA | -30.36% | ||
| ROE | -42.79% | ||
| Debt/Equity | 0 |
OASM Ownership
About OASM
Company Profile
Oasmia Pharmaceutical AB is a pharmaceutical company which develops and manufactures drugs for human and veterinary oncology. Its drugs portfolio comprises Paclical, Doxophos, Docecal and OAS-19, for human treatment as well as Paccal Vet-CA1 and Doxophos Vet, for cancer treatment in dogs, which are in different clinical phases. Oasmia Pharmaceutical AB is based in Uppsala, Sweden.
Company Info
Oasmia Pharmaceutical Ab
VALLONGATAN 1
UPPSALA V7 75228
CEO: Mikael Asp
Phone: 461-850-5440
Oasmia Pharmaceutical Ab / OASM FAQ
Can you describe the business of Oasmia Pharmaceutical Ab?
Oasmia Pharmaceutical AB is a pharmaceutical company which develops and manufactures drugs for human and veterinary oncology. Its drugs portfolio comprises Paclical, Doxophos, Docecal and OAS-19, for human treatment as well as Paccal Vet-CA1 and Doxophos Vet, for cancer treatment in dogs, which are in different clinical phases. Oasmia Pharmaceutical AB is based in Uppsala, Sweden.
Can you provide the latest stock price for Oasmia Pharmaceutical Ab?
The current stock price of OASM is 1.55 null. The price increased by 1.97% in the last trading session.
Does Oasmia Pharmaceutical Ab pay dividends?
OASM does not pay a dividend.
How is the ChartMill rating for Oasmia Pharmaceutical Ab?
OASM has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Would investing in Oasmia Pharmaceutical Ab be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on OASM.
What is the ownership structure of Oasmia Pharmaceutical Ab (OASM)?
You can find the ownership structure of Oasmia Pharmaceutical Ab (OASM) on the Ownership tab.